Cargando…
R&D Incentives for Neglected Diseases
Neglected diseases are typically characterized as those for which adequate drug treatment is lacking, and the potential return on effort in research and development (R&D), to produce new therapies, is too small for companies to invest significant resources in the field. In recent years various i...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526606/ https://www.ncbi.nlm.nih.gov/pubmed/23284648 http://dx.doi.org/10.1371/journal.pone.0050835 |